End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.93 NZD | +1.03% | -2.98% | -16.29% |
01/05 | AFT Pharmaceuticals Signs Brazil Licensing Agreement for Maxigesic IV | MT |
24/04 | New Zealand Shares Rise on US Earnings Rally; AFT Pharmaceuticals to Develop Topical Scar Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.29% | 184M | |
+32.95% | 698B | |
+26.51% | 568B | |
-4.97% | 358B | |
+18.83% | 328B | |
+3.54% | 283B | |
+16.08% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+6.70% | 165B |
- Stock Market
- Equities
- AFT Stock
- News AFT Pharmaceuticals Limited
- AFT Pharmaceuticals Secures US FDA Approval for Sale of Intravenous Pain Relief Drug